Scribe Therapeutics is a molecular engineering company focused on creating best-in-class in vivo therapies that permanently treat the underlying cause of disease. Scribe is overcoming the limitations of current genome editing technologies by developing custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine.
Employees: 11-50
Total raised: $100M
Founded date: 2017
Investors 3
| Date | Name | Website |
| - | Avoro Capi... | avorocapit... |
| - | RA Capital... | racap.com |
| - | OrbiMed | orbimed.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.03.2021 | Series B | $100M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадил... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной сви... | incrussia.... |
| 31.03.2021 | Scribe Therapeutics snags $100M for engineered CRISPR tech, ... | Scribe Therapeutics is adding another $100 million to its coffers six months after unveiling a $20 m... | fiercebiot... |
| 31.03.2021 | Scribe Therapeutics Raises $100M Series B Financing to Furth... | Scribe Therapeutics Inc., a molecular engineering company creating the most advanced technologies fo... | marketscre... |
| 31.03.2021 | Scribe Therapeutics Raises $100M Series B Financing to Furth... | - | orbimed.co... |
| 31.03.2021 | Scribe Therapeutics Scores $100M Series B | ALAMEDA, CA, Scribe Therapeutics has completed an oversubscribed $100M Series B financing led by A... | vcnewsdail... |
| 07.10.2020 | Scribe Therapeutics Procures $20M in Series A | ALAMEDA, CA, Scribe Therapeutics procures $20M in Series A Funding led by Biogen. >> Click ... | vcnewsdail... |
| 06.10.2020 | Scribe Therapeutics emerges with $20M, Biogen pact to clear ... | CRISPR evolved in bacteria as a form of “genetic vandalism,” as George Church, Ph.D., puts it, to fe... | fiercebiot... |
| 06.10.2020 | Scribe Therapeutics launches a platform for engineering CRIS... | A new company called Scribe Therapeutics founded by two former members of CRISPR pioneer Jennifer Do... | techcrunch... |
| - | Meet the top young leaders transforming the biotech industry | From left: Dr. Isaac Kinde, head of research and innovation and a co-founder of Thrive, Dr. Asima Ah... | businessin... |
| - | Meet the 30 young leaders forging a new future for the healt... | From left: Dr. Isaac Kinde, Thrive's cofounder and head of research and innovation; Dr. Asima Ahmad,... | businessin... |